Severe pyogenic infections in patients taking infliximab: a regional cohort study.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Joint, bone, spine : revue du rhumatisme

• Publication date

  2005-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.JBSPIN.2004.09.003PMID 16038846
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Infections and anti-tumor necrosis factor alpha therapy.

  2003cited by this paper
• Infections and anti–tumor necrosis factor α therapy

  2003cited by this paper
• Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial.

  2003cited by this paper
• Survival during treatment with tumour necrosis factor blocking agents in rheumatoid arthritis

  2003cited by this paper
• Severe septicaemia in a patient with polychondritis and Sweet's syndrome after initiation of treatment with infliximab.

  2003cited by this paper
• Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease?

  2003cited by this paper
• Infliximab therapy in patients with ankylosing spondylitis: an open label 12 month study

  2003cited by this paper
• Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other immune mediated inflammatory diseases (May 2003)

  2003cited by this paper
• Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy.

  2003cited by this paper
• Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy.

  2003cited by this paper
• Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report.

  2003cited by this paper
• Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.

  2002cited by this paper
• Peptostreptococcal pericarditis complicating anti-tumour necrosis factor α treatment in rheumatoid arthritis

  2002cited by this paper
• Anticorps anti-TNFα (infliximab) et tuberculose :à propos de trois cas

  2002cited by this paper
• Adverse reactions to TNF-α inhibitors in rheumatoid arthritis

  2002cited by this paper
• Recommendations about the prevention and management of tuberculosis in patients taking infliximab.

  2002cited by this paper
• Infliximab in the treatment of active and severe ankylosing spondylitis.

  2002cited by this paper
• Anti-tumour necrosis factor (TNF)-alpha therapy in undifferentiated spondyloarthropathy.

  2002cited by this paper
• What are the risks of biologic therapy in rheumatoid arthritis? An update on safety.

  2002cited by this paper
• Manual jobs increase the risk of patients with ankylosing spondylitis withdrawing from the labour force, also when adjusted for job related withdrawal in the general population

  2002cited by this paper
• The use of infliximab in academic rheumatology practice: an audit of early clinical experience.

  2002cited by this paper
• Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis.

  2002cited by this paper
• Adverse reactions to TNF-alpha inhibitors in rheumatoid arthritis.

  2002cited by this paper
• Predictors of infection in rheumatoid arthritis.

  2002cited by this paper
• [Treatment of inflammatory diseases: safety of long-term use of infliximab].

  2001cited by this paper
• “Stepping-up” from methotrexate: a systematic review of randomised placebo controlled trials in patients with rheumatoid arthritis with an incomplete response to methotrexate

  2001cited by this paper
• [Treatment of inflammatory diseases: safety of long-term use of infliximab].

  2001cited by this paper
• Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

  2000cited by this paper
• Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.

  1999cited by this paper
• Lung involvement in primary Sjögren’s syndrome is mainly related to the small airway disease

  1999cited by this paper
• Summary of clinical trials in rheumatoid arthritis using infliximab, an anti-TNFα treatment

  1999cited by this paper
• Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial

  1999influential reference
• For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group

  year unknowninfluential reference

• Incidence of severe infection in patients with rheumatoid arthritis taking biologic agents: a systematic review

  2023cites this paper
• Effectiveness and drug retention of biologic disease modifying antirheumatic drugs in Korean patients with late onset ankylosing spondylitis

  2021cites this paper
• Effectiveness and drug retention of biologic disease-modifying antirheumatic drugs in Korean patients with late-onset ankylosing spondylitis: Retrospective Cohort Study

  2021cites this paper
• Percutaneous transforaminal endoscopic discectomy for the treatment of lateral recess stenosis secondary occurred the discal fungus infection

  2020cites this paper
• Septic spondylodiscitis due to non-typhoidal Salmonella in a patient with rheumatoid arthritis treated with a TNF inhibitor and methotrexate

  2018cites this paper
• Do model polymer therapeutics sufficiently diffuse through articular cartilage to be a viable therapeutic route?

  2017cites this paper
• Pyogenic spondylodiscitis following anti-interleukin-6 therapy in a patient with rheumatoid arthritis (implication of hematogenous infection risk in degenerative intervertebral discs): A case report and review of the literature.

  2016cites this paper
• Active-comparator design and new-user design in observational studies

  2015cites this paper
• Artritis psoriásica: Contribuciones al conocimiento de su patogenia, de sus comorbilidades y al perfil de seguridad de su tratamiento

  2014cites this paper
• Can elderly people be treated safely with anti-TNF agents?

  2012cites this paper
• [Systematic review: safety and efficacy of anti-TNF in elderly patients].

  2011cites this paper
• Infections associated with the use of biologic response modifiers in rheumatic diseases: a critical appraisal

  2011cites this paper
• Revisión sistemática: eficacia y seguridad del tratamiento anti-TNF en pacientes ancianos

  2011cites this paper
• The risk of infections with biologic therapies for rheumatoid arthritis.

  2010cites this paper
• DESENLACES CLÍNICOS EN ARTRITIS REUMATOIDEA TRATADA CON INFLIXIMAB

  2009cites this paper
• Patterns of Biologic Agent Use in Older Males with Inflammatory Diseases

  2009cites this paper
• Effectiveness and safety of TNF-alpha blocking therapy in patients with rheumatoid arthritis.

  2009cites this paper
• Tolérance des glucocorticoïdes dans la polyarthrite rhumatoïde : élaboration de recommandations pour la pratique clinique, à partir d’une analyse systématique de la littérature et de l’opinion d’experts

  2008cites this paper
• Spinal infections: evolving concepts

  2008cites this paper
• Infectious Complications with Anti-TNFα Therapy in Rheumatic Diseases: A Review

  2007cites this paper
• Tumour necrosis factor inhibitors and infection: What is there to know for infectious diseases physicians?

  2006cites this paper
• Anti-tumour necrosis factor-alpha therapy for rheumatoid and other inflammatory arthropathies: update on safety in older patients.

  2006cites this paper
• Clinical evaluation of a cohort of patients with rheumatoid arthritis treated with anti-TNF-alpha in the community.

  2006cites this paper
• Infliximab for rheumatoid arthritis

  2006cites this paper
• Résultats cliniques du traitement anti-TNF-alpha dans la polyarthrite rhumatoïde traitée en ville

  2006cites this paper
• Anti-Tumour Necrosis Factor-α Therapy for Rheumatoid and Other Inflammatory Arthropathies

  2006cites this paper
• Survival and safety of treatment with infliximab in the elderly population.

  2005cites this paper